| Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta‐analysis N Mileva, S Nagumo, T Mizukami, J Sonck, C Berry, E Gallinoro, ... Journal of the American Heart Association 11 (7), e023207, 2022 | 143 | 2022 |
| Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta-analysis N Mileva, P Paolisso, E Gallinoro, D Fabbricatore, D Munhoz, ... Cardiovascular Imaging 16 (3), 376-389, 2023 | 65 | 2023 |
| Clinical validation of a virtual planner for coronary interventions based on coronary CT angiography J Sonck, S Nagumo, BL Norgaard, H Otake, B Ko, J Zhang, T Mizukami, ... Cardiovascular Imaging 15 (7), 1242-1255, 2022 | 64 | 2022 |
| Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial AC Sposito, I Breder, AAS Soares, ST Kimura-Medorima, DB Munhoz, ... Cardiovascular diabetology 20, 1-12, 2021 | 64 | 2021 |
| Differential improvement in angina and health-related quality of life after PCI in focal and diffuse coronary artery disease C Collet, D Collison, T Mizukami, P McCartney, J Sonck, T Ford, ... Cardiovascular Interventions 15 (24), 2506-2518, 2022 | 53 | 2022 |
| Microvascular dysfunction in patients with type II diabetes mellitus: invasive assessment of absolute coronary blood flow and microvascular resistance reserve E Gallinoro, P Paolisso, A Candreva, K Bermpeis, D Fabbricatore, ... Frontiers in cardiovascular medicine 8, 765071, 2021 | 53 | 2021 |
| Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography A Candreva, M Pagnoni, ML Rizzini, T Mizukami, E Gallinoro, V Mazzi, ... Atherosclerosis 342, 28-35, 2022 | 48 | 2022 |
| Contemporary management of stable coronary artery disease DT Bertolone, E Gallinoro, G Esposito, P Paolisso, K Bermpeis, ... High Blood Pressure & Cardiovascular Prevention 29 (3), 207-219, 2022 | 29 | 2022 |
| Coronary atherosclerosis phenotypes in focal and diffuse disease K Sakai, T Mizukami, J Leipsic, M Belmonte, J Sonck, BL Nørgaard, ... Cardiovascular Imaging 16 (11), 1452-1464, 2023 | 27 | 2023 |
| Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis P Paolisso, E Gallinoro, M Vanderheyden, G Esposito, DT Bertolone, ... Heart 109 (1), 47-54, 2023 | 27 | 2023 |
| Procedural outcomes after percutaneous coronary interventions in focal and diffuse coronary artery disease T Mizukami, J Sonck, K Sakai, B Ko, M Maeng, H Otake, BK Koo, ... Journal of the American Heart Association 11 (23), e026960, 2022 | 25 | 2022 |
| Safety of right and left ventricular endomyocardial biopsy in heart transplantation and cardiomyopathy patients K Bermpeis, G Esposito, E Gallinoro, P Paolisso, DT Bertolone, ... Heart Failure 10 (12), 963-973, 2022 | 22 | 2022 |
| Simplified assessment of the index of microvascular resistance M Kodeboina, S Nagumo, D Munhoz, J Sonck, N Mileva, E Gallinoro, ... Journal of Interventional Cardiology 2021 (1), 9971874, 2021 | 22 | 2021 |
| Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks J Sonck, T Mizukami, NP Johnson, S Nagumo, E Gallinoro, A Candreva, ... Catheterization and Cardiovascular Interventions 99 (5), 1518-1525, 2022 | 18 | 2022 |
| Continuous vs bolus thermodilution to assess microvascular resistance reserve E Gallinoro, DT Bertolone, T Mizukami, P Paolisso, K Bermpeis, ... Cardiovascular Interventions 16 (22), 2767-2777, 2023 | 17 | 2023 |
| Impact of post-PCI FFR stratified by coronary artery C Collet, NP Johnson, T Mizukami, WF Fearon, C Berry, J Sonck, ... Cardiovascular Interventions 16 (19), 2396-2408, 2023 | 16 | 2023 |
| Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial AC Sposito, I Breder, J Barreto, J Breder, I Bonilha, M Lima, A Oliveira, ... Cardiovascular diabetology 21 (1), 147, 2022 | 15 | 2022 |
| Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized … RMR Cintra, AAS Soares, I Breder, DB Munhoz, J Barreto, ... Diabetology & metabolic syndrome 11, 1-12, 2019 | 15 | 2019 |
| Implementing healthcare professionals’ training during COVID-19: A pre and post-test design for simulation training TM Santos, RBS Pedrosa, DRS Carvalho, MH Franco, JLG Silva, D Franci, ... Sao Paulo Medical Journal 139 (5), 514-519, 2021 | 12 | 2021 |
| Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus VLW Wolf, I Breder, LSF de Carvalho, AAS Soares, RM Cintra, J Barreto, ... Nutrition & Diabetes 11 (1), 17, 2021 | 12 | 2021 |
